Ocugen Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Ocugen has a total shareholder equity of $16.9M and total debt of $2.9M, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are $40.5M and $23.6M respectively.
Wichtige Informationen
16.9%
Verhältnis von Schulden zu Eigenkapital
US$2.86m
Verschuldung
Zinsdeckungsgrad | n/a |
Bargeld | US$15.70m |
Eigenkapital | US$16.93m |
Gesamtverbindlichkeiten | US$23.62m |
Gesamtvermögen | US$40.54m |
Jüngste Berichte zur Finanzlage
Recent updates
Ocugen announces peer-reviewed publication on COVID-19 vaccine
Sep 14Ocugen initiated with Buy at Mizuho citing favorable setup ahead of key readout
Aug 23Ocugen Q2 2022 Earnings Preview
Aug 04Ocugen: A First Take
Jul 18Ocugen in renewed focus as FDA wants COVID boosters to fight Omicron variant
Jul 05Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: OCGN's short term assets ($18.6M) exceed its short term liabilities ($18.0M).
Langfristige Verbindlichkeiten: OCGN's short term assets ($18.6M) exceed its long term liabilities ($5.6M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: OCGN has more cash than its total debt.
Schulden abbauen: OCGN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: OCGN has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Vorhersage Cash Runway: OCGN is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.